Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-15 Purchase(A) | 2024-10-22 5:31 pm | Camp4 Therapeutics Corp | CAMP | Polaris Management Co. VII L.L.C. Polaris Partners VII L.P. Polaris Entrepreneurs' Fund VII L.P. Polaris Partners X L.P. Polaris Partners GP X L.L.C. SCHULMAN AMY W Chee Brian 10% Owner | 909,090 | $11 | $9,999,990 | 909,090 (Indirect) | View |
| 2024-10-15 Purchase | 2024-10-15 6:00 pm | Camp4 Therapeutics Corp | CAMP | Polaris Management Co. VII L.L.C. Polaris Partners VII L.P. Polaris Entrepreneurs' Fund VII L.P. Polaris Partners X L.P. Polaris Partners GP X L.L.C. SCHULMAN AMY W 10% Owner | 909,090 | $11 | $9,999,990 | 909,090 (Indirect) | View |
| 2024-06-25 Sale | 2024-06-27 4:04 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 8,500 | $240 | $2,040,000 | 11,186 (Direct) | View |
| 2024-05-29 Sale | 2024-05-31 7:00 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 21,700 | $148.6 | $3,224,546 | 8,436 (Direct) | View |
| 2021-12-13 Purchase | 2021-12-15 5:15 pm | SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner | 3,700 | $10.91 | $40,367 | 3,196,040 (Indirect Direct) | View |
| 2020-11-03 Purchase | 2020-11-03 8:00 pm | SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner | 250,000 | $16 | $4,000,000 | 2,739,990 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-15 Conversion(A) | 2024-10-22 5:31 pm | N/A N/A | Camp4 Therapeutics Corp | CAMP | Polaris Management Co. VII L.L.C. Polaris Partners VII L.P. Polaris Entrepreneurs' Fund VII L.P. Polaris Partners X L.P. Polaris Partners GP X L.L.C. SCHULMAN AMY W Chee Brian 10% Owner | 20,962,046 | $0 | 909,090 (Indirect) | View |
Ownership(A) | 2024-10-22 5:05 pm | N/A N/A | Camp4 Therapeutics Corp | CAMP | Polaris Partners GP X L.L.C. Polaris Partners X L.P. SCHULMAN AMY W Chee Brian 10% Owner | 0 | $0 | 909,090 (Indirect) | View |
| 2024-10-15 Conversion | 2024-10-15 6:00 pm | N/A N/A | Camp4 Therapeutics Corp | CAMP | Polaris Management Co. VII L.L.C. Polaris Partners VII L.P. Polaris Entrepreneurs' Fund VII L.P. Polaris Partners X L.P. Polaris Partners GP X L.L.C. SCHULMAN AMY W 10% Owner | 20,962,046 | $0 | 909,090 (Indirect) | View |
Ownership | 2024-10-15 5:32 pm | N/A N/A | Camp4 Therapeutics Corp | CAMP | Polaris Partners GP X L.L.C. Polaris Partners X L.P. SCHULMAN AMY W 10% Owner | 0 | $0 | 909,090 (Indirect) | View |
| 2024-06-25 Exercise | 2024-06-27 4:04 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 8,500 | $131.21 | 11,186 (Direct) | View |
| 2024-06-25 Exercise | 2024-06-27 4:04 pm | 2016-06-01 2025-06-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 8,500 | $0 | 11,186 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-31 7:00 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 30,000 | $66.83 | 8,436 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-31 7:00 pm | N/A 2024-07-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 30,000 | $0 | 8,436 (Direct) | View |
| 2024-05-16 Option Award | 2024-05-20 4:04 pm | 2025-05-16 2034-05-16 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 5,228 | $0 | 5,228 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 5:05 pm | N/A 2034-01-31 | Fractyl Health Inc. | GUTS | SCHULMAN AMY W Director | 45,000 | $0 | 45,000 (Direct) | View |
Ownership | 2024-02-01 6:13 pm | N/A 2028-08-29 | Fractyl Health Inc. | GUTS | SCHULMAN AMY W Director | 0 | $0 | 140,783 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 4:46 pm | N/A 2033-06-13 | SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner | 39,875 | $0 | 39,875 (Direct) | View |
| 2023-05-18 Option Award | 2023-05-19 4:04 pm | 2024-05-18 2033-05-18 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 3,454 | $0 | 3,454 (Direct) | View |
| 2023-02-23 Exercise | 2023-02-27 4:13 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 136 | $0 | 136 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 5:01 pm | N/A 2032-06-14 | SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-05-18 Option Award | 2022-05-20 4:06 pm | 2023-05-18 2032-05-17 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 5,153 | $0 | 5,153 (Direct) | View |
| 2022-02-23 Option Award | 2022-02-25 4:09 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 136 | $0 | 136 (Direct) | View |
| 2021-12-22 Exercise | 2021-12-23 5:15 pm | N/A N/A | SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner | 10,091 | $2.02 | 3,229,480 (Direct) | View |
| 2021-12-22 Exercise | 2021-12-23 5:15 pm | N/A N/A | SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner | 14,039 | $4.59 | 3,229,480 (Direct) | View |
| 2021-12-22 Exercise | 2021-12-23 5:15 pm | N/A 2028-03-04 | SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner | 24,130 | $0 | 3,229,480 (Direct) | View |
| 2021-10-27 Option Award | 2021-10-29 4:07 pm | 2022-10-27 2031-10-26 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 1,814 | $0 | 1,814 (Direct) | View |
| 2021-07-15 Option Award | 2021-07-19 4:21 pm | 2022-07-15 2031-07-14 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 4,032 | $0 | 4,032 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-17 5:16 pm | N/A 2031-06-14 | SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner | 10,500 | $0 | 10,500 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:00 pm | N/A N/A | SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner | 5,411,716 | $0 | 2,739,990 (Indirect) | View |
| 2020-10-29 Option Award | 2020-10-30 6:30 pm | N/A 2030-10-28 | SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner | 7,055 | $0 | 7,055 (Direct) | View |
Ownership | 2020-10-29 8:50 pm | N/A N/A | SQZ Biotechnologies Co | SQZ | SCHULMAN AMY W Director 10% Owner | 0 | $0 | 2,975,780 (Direct) | View |
| 2020-07-01 Option Award | 2020-07-06 4:50 pm | 2021-07-01 2030-07-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 4,581 | $0 | 4,581 (Direct) | View |
| 2020-06-16 Option Award | 2020-06-18 4:15 pm | N/A 2030-06-16 | Cyclerion Therapeutics Inc. | CYCN | SCHULMAN AMY W Director | 10,000 | $0 | 10,000 (Direct) | View |
Ownership | 2020-06-08 7:29 pm | N/A N/A | Hudson Executive Investment Corp. | HEC | SCHULMAN AMY W Director | 0 | $0 | 25,000 (Direct) | View |